Explaining high alloreactivity as a quantitative consequence of affinity-driven thymocyte selection

door Detours, Vincent, Perelson, Alan S.
Gepubliceerd in 1999

The paradox of alloreactivity and self MHC restriction: Quantitative analysis and statistics

door Detours, Vincent, Perelson, Alan S.
Gepubliceerd in 2000

Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy

door Kim, Hwijin, Perelson, Alan S
Gepubliceerd in 2006

Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips

door Rong, Libin, Perelson, Alan S.
Gepubliceerd in 2008

Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy

door Rong, Libin, Perelson, Alan S.
Gepubliceerd in 2009

Modeling HIV persistence, the latent reservoir, and viral blips

door Rong, Libin, Perelson, Alan S.
Gepubliceerd in 2009

Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling

door Rong, Libin, Perelson, Alan S.
Gepubliceerd in 2010

Second phase HCV RNA decline during telaprevir based therapy increases with drug effectiveness: implications for treatment duration

door Guedj, Jeremie, Perelson, Alan S.
Gepubliceerd in 2011

Contribution of Follicular Dendritic Cells to Persistent HIV Viremia

door Zhang, Jingshan, Perelson, Alan S.
Gepubliceerd in 2013

Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents

door Rong, Libin, Perelson, Alan S.
Gepubliceerd in 2013

Contribution of Follicular Dendritic Cells to Persistent HIV Viremia

door Zhang, Jingshan, Perelson, Alan S.
Gepubliceerd in 2013

Hepatitis C virus RNA kinetics: Drug efficacy and the rate of HCV-infected cells loss

door Dahari, Harel, Perelson, Alan S
Gepubliceerd in 2007

Viral Kinetic Modeling: State of the Art

door Canini, Laetitia, Perelson, Alan S.
Gepubliceerd in 2014

The challenges of modelling antibody repertoire dynamics in HIV infection

door Luo, Shishi, Perelson, Alan S.
Gepubliceerd in Philos Trans R Soc Lond B Biol Sci (2015)

Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising

door Luo, Shishi, Perelson, Alan S.
Gepubliceerd in Proc Natl Acad Sci U S A (2015)

Modelling hepatitis C therapy—predicting effects of treatment

door Perelson, Alan S., Guedj, Jeremie
Gepubliceerd in Nat Rev Gastroenterol Hepatol (2015)

Modeling Viral Spread

door Graw, Frederik, Perelson, Alan S.
Gepubliceerd in Annu Rev Virol (2016)

Mathematical modeling of within host Zika virus dynamics

door Best, Katharine, Perelson, Alan S.
Gepubliceerd in Immunol Rev (2018)

Mechanistic modelling of SARS-CoV-2 and other infectious diseases and the effects of therapeutics

door Perelson, Alan S., Ke, Ruian
Gepubliceerd in Clin Pharmacol Ther (2021)

Drug concentration heterogeneity facilitates the evolution of drug resistance

door Kepler, Thomas B., Perelson, Alan S.
Gepubliceerd in 1998